Sidoti Csr Expects Weaker Earnings for USANA Health Sciences

USANA Health Sciences, Inc. (NYSE:USNA) – Stock analysts at Sidoti Csr reduced their Q1 2025 earnings per share (EPS) estimates for shares of USANA Health Sciences in a research report issued on Tuesday, February 18th. Sidoti Csr analyst A. Lebiedzinski now forecasts that the company will post earnings of $0.77 per share for the quarter, down from their previous forecast of $0.84. The consensus estimate for USANA Health Sciences’ current full-year earnings is $2.45 per share. Sidoti Csr also issued estimates for USANA Health Sciences’ Q2 2025 earnings at $0.68 EPS, Q3 2025 earnings at $0.70 EPS, Q4 2025 earnings at $0.74 EPS, FY2025 earnings at $2.89 EPS, Q1 2026 earnings at $0.89 EPS, Q2 2026 earnings at $0.86 EPS, Q3 2026 earnings at $0.90 EPS and FY2026 earnings at $3.59 EPS.

USNA has been the topic of a number of other reports. DA Davidson raised their price target on shares of USANA Health Sciences from $35.00 to $38.00 and gave the company a “neutral” rating in a research note on Thursday, January 2nd. StockNews.com downgraded USANA Health Sciences from a “strong-buy” rating to a “buy” rating in a research report on Friday, February 14th.

USANA Health Sciences Stock Down 0.8 %

USNA opened at $31.16 on Thursday. The firm’s fifty day simple moving average is $34.02 and its two-hundred day simple moving average is $36.85. USANA Health Sciences has a 52-week low of $30.13 and a 52-week high of $50.32. The company has a market cap of $593.99 million, a price-to-earnings ratio of 11.01, a PEG ratio of 0.85 and a beta of 0.87.

Institutional Investors Weigh In On USANA Health Sciences

A number of hedge funds have recently modified their holdings of the business. R Squared Ltd acquired a new stake in shares of USANA Health Sciences in the fourth quarter valued at approximately $28,000. Safe Harbor Fiduciary LLC purchased a new stake in USANA Health Sciences in the 3rd quarter valued at $30,000. KBC Group NV increased its stake in shares of USANA Health Sciences by 96.6% in the 3rd quarter. KBC Group NV now owns 1,056 shares of the company’s stock worth $40,000 after acquiring an additional 519 shares during the last quarter. KLP Kapitalforvaltning AS purchased a new position in shares of USANA Health Sciences during the 4th quarter worth $83,000. Finally, Quantbot Technologies LP acquired a new position in shares of USANA Health Sciences during the 4th quarter valued at about $132,000. 54.25% of the stock is currently owned by institutional investors and hedge funds.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.